Ischemic Stroke Clinical Trial
— TRATTOfficial title:
Inter-Hospital Transfer to a Vascular Neurology Unit After Telethrombolysis in France Comté
| NCT number | NCT02902263 |
| Other study ID # | P/2015/248 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | January 2014 |
| Est. completion date | January 2016 |
| Verified date | September 2016 |
| Source | Centre Hospitalier Universitaire de Besancon |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Early thrombolysis is essential in treating ischemic strokes. The time window for
thrombolysis is limited to 4,5 hours after symptoms onset.
In the French region of Franche Comté, in order to reduce the thrombolytic delay, a
telemedicine network was developed between the neurovascular reference unit (NVU) localised
in the University Hospital of Besançon and the peripheral hospital centres. Patients may then
be transported to the NVU immediately after the thrombolysis initiation.
The aim of our study was to assess the relevance of a systematic medicalization of transfer
to the NVU of patients with stroke who were telethrombolyzed before.
It was a retrospective, monocentric and observational study conducted over 24 months, in
Franche-Comte (France).
| Status | Completed |
| Enrollment | 79 |
| Est. completion date | January 2016 |
| Est. primary completion date | May 2015 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patient with ischaemic stroke - Emergency department admission between 01/01/2012 and 12/31/2013 - Telemedicine stroke consult - Thrombolysis therapy - Patient transfered to NVU after thrombolysis initiation - Transfer staffed by a qualified physician Exclusion Criteria: - Transfer non staffed by a qualified physician |
| Country | Name | City | State |
|---|---|---|---|
| France | CHRU Besancon | Besançon |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Besancon |
France,
Nenert E, Pretalli JB, Bouamra B, Puyraveau M, Fehner L, Labourey JM, Desmettre T. Transfert interhospitalier vers une unité de neurologie vasculaire des accidents vasculaires cérébraux ischémiques téléthrombolysés : pertinence d'une médicalisation systém
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Patient neurological status assessed by NIHSS score during transfer to NVU | one day | ||
| Primary | Patient neurological status assessed by Glasgow score during transfer to NVU | one day | ||
| Secondary | Patient respiratory status assessed by oxygen saturation | one day | ||
| Secondary | Patient hemodynamic status assessed by systolic and diastolic pressure | one day |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |